An Efficacy Study of a Single Dose Treatment of PRO-513 for Subjects Suffering a Migraine Attack
Clinical trial NCT00330850 · COMPLETED
Trial details
- NCT number
- NCT00330850
- Sponsor
- ProEthic Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Enrollment
- 650
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.